Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics

Subjects undergo vitreous substitution with either SF6 gas or fluid during vitrectomy.

vitrectomy
vitreous hemorrhage
diabetes
  • 20 views
  • 19 Mar, 2021
  • 1 location
Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients

The purpose of this study is to determine whether bevacizumab 1-2 weeks before vitrectomy is effective in lowering the rate of early post-vitrectomy vitreous hemorrhage in diabetic

vitrectomy
retinopathy
bevacizumab
vitreous hemorrhage
  • 7 views
  • 07 Nov, 2020
  • 1 location
Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria

o'clock, mild proliferative vitreoretinopathy, none or mild vitreous hemorrhage. Patients will be excluded if there is a small retinal tear or multiple tears less than 30o apart between 8 and 4 o'clock in

  • 0 views
  • 23 Jan, 2021
  • 2 locations
25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial

Proliferative diabetic retinopathy(PDR) is the leading cause of visual loss in diabetic patients. Operation is an efficient method to treat PDR. Anti-vascular endothelial growth factor (anti-VEGF) can be used as an adjuvant therapy which can make operation more easy.

vitrectomy
detachment
type 2 diabetes mellitus
adjuvant therapy
retinopathy
  • 5 views
  • 22 Jan, 2021
  • 1 location
Combination of Ranibizumab and Targeted Laser Photocoagulation

Intravitreal injections of Ranibizumab will be applied in all patients according to treatment guidelines. The experimental group will receive additional targeted laser photocoagulation of the peripheral areas of capillary non-perfusion (up to 4 laser treatments within 1st year of the study). Based on the long-term observation after CoRaLa I study …

  • 0 views
  • 25 Jan, 2021
  • 8 locations
Intravitreal Bevacizumab for Retinal Disorders

Bevacizumab is an anti-VEGF agent used in approved for use in metastatic colorectal carcinoma (FDA Approved). This study analyzes the safety and efficacy of off-label Intravitreal Injection of bevacizumab (Avastin) for CNVM, Macular oedema due to diabetic retinopathy, vascular occlusion and other retinal disorders.

macular edema
diabetic retinopathy
other retinal disorders
edema
macular degeneration
  • 23 views
  • 07 Nov, 2020
  • 1 location
Pars Plana Vitrectomy With 25-gauge 20000 Cpm Bevel-tip Cutter

Report efficiency and clinical outcomes using 25-gauge, bevel-tip, 20000 cut per minute vitrectomy probe among eyes with various vitreo-retinal diseases

vitrectomy
probe
  • 0 views
  • 14 Jun, 2021
  • 1 location
Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage

The Purpose of this study is compare the efficacy of intravitreal triamcinolone in clearing recurrent post-vitrectomy diabetic hemorrhage with conventional treatment, air-fluid exchange.

  • 21 views
  • 07 Nov, 2020
  • 1 location
Objective Measurements of the Opacification of the Lens After Vitrectomy

membranes, macular holes, vitreous hemorrhage. The incidence of post-vitrectomy cataract varies among studies, and the methodology is often retrospective. Age has already been identified as a risk factor

bilateral cataracts
retinal detachment
  • 0 views
  • 26 Jan, 2021
  • 1 location
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging

Subjects undergoing ILM peeling during vitrectomy will have better visual acuity and lower rates of DME to control subjects

vitrectomy
diabetic retinopathy
diabetes
proliferative diabetic retinopathy
retinopathy
  • 21 views
  • 18 Mar, 2021
  • 1 location